Purdue Agribusiness Review, Volume 1, Issue 2
When more stops meaning better
For much of the last three decades, the agricultural input industry followed a simple idea: own more of the acre.
The logic was easy to understand. A company that could influence both what the farmer planted and what the farmer sprayed would have a stronger competitive position than a company selling only one part of the crop program. Seeds, chemistry, traits, biologicals, digital tools and agronomic advice were all expected to reinforce each other. The broader the portfolio, the stronger the position.
That thinking shaped one of the largest consolidation waves the industry has ever seen. Bayer paid $63 billion for Monsanto in 2018, the largest all-cash takeover in corporate history[1]. ChemChina acquired Syngenta for $43 billion[2]. Dow and DuPont merged and eventually created Corteva[3]. Integration became the dominant strategic logic across the industry.
Yet recent restructuring decisions suggest a more complicated question. Rather than pointing to a single industry-wide shift, they indicate growing pressure on the assumption that broader portfolios always create more value. As businesses inside agricultural input companies become more technologically, economically and organizationally distinct, the challenge of managing them through a common structure appears to be increasing.
The clearest recent example came from Corteva, which announced plans to separate its seeds and crop protection businesses[4]. That decision raises a harder question about whether two categories once seen as naturally connected may now have different enough economics, capabilities and investor expectations that they create more value apart than together.
The rest of the industry now faces a difficult question. Is Corteva’s move a company-specific decision, or is it an early indication that the conditions under which integration creates value are becoming narrower than many executives assumed?
[1] Bayer. (2018, September 5). Bayer completes biggest acquisition in its history. https://www.bayer.com/media/en-us/bayer-completes-biggest-acquisition-in-its-history/
[2] Reuters. (2017, May 5). ChemChina clinches landmark $43 billion takeover of Syngenta. https://www.reuters.com/article/world/chemchina-clinches-landmark-43-billion-takeover-of-syngenta-idUSKBN1810CM/
[3] DuPont Investor Relations. (2019, May 7). DowDuPont board of directors approves Corteva distribution and announces effectiveness of Form 10 registration statement for Corteva. https://www.investors.dupont.com/news-and-media/press-release-details/2019/DowDuPont-Board-of-Directors-Approves-Corteva-Distribution-and-Announces-Effectiveness-of-Form-10-Registration-Statement-for-Corteva/default.aspx
[4] Corteva Agriscience. (2025, October 1). Corteva announces plan to separate into two industry-leading public companies. https://www.corteva.com/resources/media-center/corteva-announces-plan-to-separate-into-two-industry-leading-public-companies.html
Why this is hard
The integrated model was built on solid logic and, for years, made a great deal of sense. A company that could sell seeds, chemistry, traits, biologicals and agronomic advice together had a stronger position with the farmer than a narrow specialist selling a single product. The conversation could move from what to plant, to how to protect it, to how to improve yields across the season.
There were practical advantages too. Commercial teams could cover more categories without a proportional increase in cost. Rebate programs encouraged farmers and distributors to buy across the portfolio rather than mix and match suppliers. Large integrated players also had stronger leverage with distributors, retailers and raw material suppliers. In many markets, that scale mattered. A focused specialist might have a better product in one category, but it rarely had the same reach, negotiating power or ability to stay in front of the customer throughout the season.
Integration can still create value. The challenge is that the businesses inside these portfolios are becoming more increasingly distinct. Many agricultural companies are trying to run them through the same structures, incentives and planning cycles. That is becoming harder to do well.
Seeds still behave like a classic IP business. Long development cycles, strong royalty streams and margins tied to genuine biological differentiation give the category an economic profile closer to pharma than to manufacturing. Crop protection increasingly follows a different logic. Generic pressure, patent cliffs and tightening regulation are making many portfolios resemble mature industrial businesses more than differentiated innovation engines.
Digital agriculture brings yet another operating model. Software teams often depend on rapid iteration, user testing and product managers who can change direction quickly. Most crop input companies, by contrast, are built around annual planning cycles, seasonal launches and lengthy approval chains. That mismatch appears may matter more than many executives expected. Carbon and regenerative agriculture programs stretch the model further still, often requiring years of farmer engagement before the value becomes visible.
Biologicals may be one of the clearest examples of the challenge,though perhaps not in the way it is sometimes framed. A common argument is that biologicals and chemistry simply do not belong together. That interpretation may oversimplify the problem. Biologicals can genuinely complement crop protection: an inoculant that improves nitrogen uptake alongside a herbicide, a biostimulant that supports a fungicide program. The products are not inherently incompatible.
What is likely harder is building an organization capable of running both effectively at the same time. Biological products often involve different development cycles, more variable performance across geographies and soil types, more localized field testing requirements and a subtler value proposition centered on resilience and soil health rather than the more visible yield gains chemistry can usually promise. A sales force trained to move broad-acre chemistry in volume is not naturally equipped to make that case. A regulatory team built around synthetic molecules is not naturally equipped for microbial approval pathways. The capabilities differ even if the customer does not.
Whether integrated chemical and biological businesses can be designed to run both effectively remains unresolved. The answer may depend as much on organizational architecture as portfolio construction. Putting both businesses inside the same legal entity is straightforward. Building an organization that can actually run them well is far harder.
Conglomerates also face a structural investor problem that compounds the operational one. When the market believes the businesses inside a portfolio have sufficiently different economics and risk profiles, it may begin to apply a diversification discount. The integrated giants built during the consolidation wave were valued on the assumption that cross-category synergies would materialize. If those synergies prove weaker than expected, or investors become less convinced they will emerge, pressure to simplify becomes financial as well as strategic.
The industry is already restructuring
The recent wave of corporate activity suggests the debate has moved well past the theoretical. What is emerging across the industry is a broader willingness to question the assumptions that shaped the consolidation era and explore multiple strategic paths.
Corteva’s announced separation of seeds and crop protection is perhaps the clearest example of a company explicitly questioning whether businesses long assumed to belong together may need different homes. Seeds benefit from IP protection, royalty income and long innovation cycles that reward patient capital. Crop protection faces generic erosion, manufacturing intensity and a regulatory environment that is tightening in most major markets. The capital requirements, talent profiles and strategic time horizons of the two businesses have diverged to the point where a shared structure may create more friction than advantage. Corteva’s decision to separate them reflects one response to that challenge: greater focus and organizational clarity.
UPL illustrates a different response to similar pressures. The company is combining its India crop protection operations and its international crop protection and biologicals business into a new listed entity, UPL Global, while seeds sit separately through Advanta and specialty chemicals remain elsewhere in the group. The rationale is straightforward: different businesses require different governance structures, capital allocation priorities, and organizational cultures. Rather than fully separating capabilities, UPL appears to be reorganizing around a different operating structure – one intended to provide greater focus and strategic coherence while preserving selected forms of integration.
FMC illustrates a different version of the same story, shaped more directly by financial and competitive pressure. The company has faced severe pressure as flagship products move off-patent and generic competition from lower-cost manufacturers intensifies[5]. A large share of EBITDA is now exposed to that erosion. The response – asset sales, debt reduction, a sharpened focus on differentiated chemistry – suggests that a broad portfolio alone does not compensate for weakening differentiation. In FMC’s case, restructuring appears driven at least as much by deteriorating economics as by a deliberate shift in how the business should be organized.
BASF presents yet another variation. The company is preparing an IPO of its agriculture division, which runs close to €10 billion in annual revenue and invests roughly €1 billion per year in R&D[6]. The separation work is already progressing across systems, reporting lines and regional structures. Importantly, BASF does not appear to be abandoning an integrated crop systems logic. The argument instead it is that a more focused agricultural business, with a clearer strategic story and greater capital visibility, may perform better under a different ownership and governance structure than a division embedded in a chemicals conglomerate with multiple competing claims on capital.
Not every company is moving in the same direction. Nufarm chose not to separate parts of its portfolio after weak margins in omega-3 canola, opting instead for internal restructuring and a focus on hybrids and bioenergy partnerships[7]. That decision may ultimately prove correct or not. The point is less that every company is breaking itself apart than that more companies appear willing to subject inherited assumptions about integration to explicit strategic scrutiny rather than treating greater breadth as self-evidently valuable.
Taken together, these examples suggest less a common destination than a shared pressure. Companies across the sector are responding to many of the same forces – generic erosion, biological disruption, digital capabilities, regulatory tightening, challenged farming economics, and investor scrutiny – but in different ways. Some are simplifying. Some are reconfiguring. Some are doubling down on integration under different organizational arrangements. What appears increasingly under pressure is not integration itself, but the assumption that broader portfolios automatically create greater value.
[5] FMC Corporation Investor Relations. (2026, February 4). FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company. https://investors.fmc.com/news/news-details/2026/FMC-Corporation-sets-2026-priorities-and-announces-exploration-of-strategic-options-including-but-not-limited-to-the-sale-of-the-company/default.aspx
[6] BASF. (2025, October 2). BASF presents progress on “Winning Ways” strategy. https://www.basf.com/cn/en/media/news-releases/global/2025/10/cn-25-117
[7] Alsop, E. (2025, November 19). Nufarm opts to keep seed tech business after review. Grain Central. https://www.graincentral.com/news/nufarm-opts-to-keep-seed-tech-business-after-review/
Managerial Implications: Three paths, not one
The most important shift in thinking executives may need to make is this: the central question has moved beyond choosing between integration and specialization in the abstract. Instead, the challenge is determining which organizational model best fits the capabilities a company actually has. That is a harder question, and it does not have a generic answer.
What is becoming increasingly visible is that the agricultural input industry may be sorting itself into three distinct competitive models. Understanding which one a company is, or which one it has the realistic potential to become, may be one of the more consequential strategic questions facing leaders today.
The first model is the integrated giant. These businesses win through scale, distribution reach and the ability to spread R&D across huge volumes. But scale alone is not enough. Many companies describe themselves as integrated while managing a collection of underfunded units with little in common beyond the logo on the building. For this model to work, the organization inside the company needs to be more flexible than the portfolio outside. Biologicals, digital tools and carbon services cannot necessarily be managed in the same way as crop protection, just at smaller scale. They often require different teams, incentives, metrics and operating rhythms, even when they remain part of the same company.
The integrated model is most viable when cross-category synergies are real rather than assumed, when shared customer access, R&D, distribution or agronomic outcomes create value that independent businesses would struggle to replicate. The principal risk is organizational complexity. Companies can become broad without becoming genuinely integrated.
The second model is the specialist. These companies focus on one capability and aim to become meaningfully better than competitors in that area. It could be a gene-editing company focused entirely on traits, a fermentation business building the best microbial manufacturing platform in the industry or a precision application company investing heavily in sensors and variable-rate technology.
These companies do not need to win across the whole acre. They need to be clearly better at one important thing. In some cases, specialists become strong enough that large integrated players decide partnership, licensing or acquisition is more attractive than building the capability internally.
That approach comes with risks. Specialists can end up too exposed to a single technology, a change in regulation or a limited number of customers or distribution partners. But as capabilities become more specialized and harder to master, deep expertise in one area may become more valuable than being moderately good across many.
The third model is the ecosystem orchestrator. These businesses do not own every capability but are particularly effective at combining genetics, chemistry, biologicals, digital tools, financing and sustainability programs into a coherent offer for the farmer. Their advantage is their ability to connect other people’s capabilities in a way that creates value the farmer cannot easily assemble independently.
This model depends on a different set of skills. Companies need to know how to find the right partners, manage relationships across different types of businesses and build commercial agreements that keep everyone aligned. They also need a clear enough value proposition that farmers continue to see them as essential, even when many of the underlying products come from other companies. Very few businesses have been built around this logic so far. But in a market where capabilities are becoming more specialized and harder for any one company to own internally, ecosystem coordination may become increasingly valuable.
Across all three models, the most important thing is clarity. Companies are generally better served by committing to one model than attempting to combine several without sufficient scale, differentiation or organizational discipline.
The businesses most exposed are those stuck in between: integrated players without the scale or organizational capability to make integration work, specialists without enough differentiation to stand out, or orchestrators without the partnerships, credibility or coordination capabilities to align others effectively. Periods of structural change often penalize companies without a clear source of advantage.
What to watch going forward
Several signals may help indicate whether these structural pressures are intensifying and which competitive model is gaining ground.
The first signal lies inside organizations themselves. Spin-offs and IPOs attract attention, but the more important signals often come earlier and at a lower level of visibility.
One useful question is how companies organize emerging capabilities internally. Are biologicals businesses given their own leadership teams and P&L responsibility? Are digital agriculture platforms allowed to follow software development cycles rather than seasonal sales cycles? Are carbon and sustainability programs part of the core commercial model, or are they sitting off to the side as separate teams?
These organizational decisions often provide a clearer indication of what management really believes about which businesses belong together – often more clearly than any investor presentation or strategy update. They reveal what leadership believes belongs together, which capabilities require autonomy and where integration is still considered valuable.
A second signal is how dealmaking changes. The previous wave of consolidation was built around large acquisitions and mega-mergers. The next phase may look very different.
Instead of buying entire companies, large players are increasingly making minority investments, signing licensing agreements, forming joint ventures and acquiring small specialist businesses earlier in their development. If this pattern strengthens, it may suggest an industry moving toward a more networked model in which companies connect capabilities rather than trying to own everything directly.
That shift would not necessarily favor companies with the largest balance sheets. It may instead reward firms that can build partnerships and bring diverse capabilities together around the farmer.
A third signal is talent allocation. If companies increasingly recruit from software, synthetic biology, data science, fermentation or carbon markets rather than traditional crop chemistry, it may indicate that competitive advantage is shifting toward new forms of capability.
The companies that recognize this early will build very different kinds of businesses. Those that continue to recruit mainly for the skills that mattered in the old model may find themselves falling behind specialists that are more focused and easier to adapt.
A final signal may come from farmers themselves. Growers are often more informed, more selective and more willing to combine products and services from different suppliers if they believe it gives them a better result. A farmer who once relied heavily on a single broad-portfolio supplier is increasingly willing to choose one company for biologicals, another for digital tools and another for chemistry.
No single season is likely to make this shift obvious. But over time, changes in farmer purchasing behavior may provide one of the clearest indicators of whether integrated offerings continue to create sufficient value to hold together.
The integration logic that shaped the industry for the last thirty years still has value, but it may be sufficient on its own. The companies that built large portfolios around the idea of owning more of the acre now face a harder question: under what conditions does breadth genuinely create value, and when does organizational focus create more?
About the Center for Food and Agricultural Business
Founded in 1986, the Purdue University Center for Food and Agricultural Business is celebrating 40 years of working with the agribusiness industry to develop leaders and inform better decision-making. Housed within Purdue’s Department of Agricultural Economics, the center connects faculty expertise with the practical challenges facing food and agricultural companies.
The center delivers professional development programs, industry research and graduate education designed specifically for agribusiness professionals. Offerings include open-enrollment workshops, custom corporate training and the MS-MBA in Food and Agribusiness Management, a dual-degree program developed with industry for working professionals.
Through its research and publications – including the Purdue Agribusiness Review – the center shares industry insights from Purdue faculty and collaborators to help agribusiness leaders navigate change and make more informed strategic decisions.
